Anzeige
Mehr »
Login
Mittwoch, 25.09.2024 Börsentäglich über 12.000 News von 690 internationalen Medien
BREAKING NEWS: Nachbörsliche Hammermeldung - explodiert die Aktie morgen weiter?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
237 Leser
Artikel bewerten:
(1)

COVID-19 Helps Drive Electronic Skin Patches Market to $10bn in 2021 Finds New IDTechEx Report

BOSTON, June 28, 2021 /PRNewswire/ -- IDTechEx have released their latest report on Electronic Skin Patches. The report, titled "Electronic Skin Patches 2021-2031", covers the market, technology, and players in this unique product sector, and predicts that the sector will be worth $10bn in annual revenue in 2021. The report captures the impact of the COVID-19 pandemic, covering the impact for each sector throughout 2020 and 2021, and the overall impact relative to the broader emerging trends across the relevant product sectors.

28 application areas discussed within the report. Source IDTechEx -

Having covered the subject over the last decade as part of wider research efforts in wearables and medical devices, this report looks chapter by chapter at each of the key market sectors involved. Diabetes management is the largest and most successful sector, predominantly with CGM but also increasing adoption of patch pumps for insulin delivery and moves towards closed-loop systems. Cardiovascular monitoring is the other sector generating revenue in the billions of dollars each year but is far more fragmented in terms of players, product trends, and geographies. These skin patch cardiovascular monitors are increasingly at the center of an expansion to a more general approach to patient monitoring, both for hospital inpatients and beyond into various outpatient applications. Other sectors such as temperature-based monitoring (fever monitoring, fertility monitoring), electrical stimulation devices, iontophoresis, and other patient monitoring devices are also characterized, each with unique competitive landscapes and drivers.

On the impact of COVID-19, James Hayward, Principal Analyst at IDTechEx and lead author of the report, said: "Rather than any lasting negative impact as seen elsewhere, the COVID-19 pandemic has led to an acceleration in many of the key trends underpinning the development of this market. Wider adoption of telehealth, additional drivers for remote patient monitoring, and larger-scale adoption of digital patient management solutions were all trends which we covered previously, but the acceleration in each has left us 2 years ahead of our original projections for their widespread adoption."

The report goes into more detail about the drivers behind this change. Initial lockdowns caused a significant negative impact in many sectors due to the postponement of "non-essential" physician visits. However, many companies immediately shifted to more telehealth-based services which helped to meet the demand. In addition, regulatory barriers were lowered, allowing many products to receive emergency approvals and advance their commercialization and deployment faster than they would normally have been able to. This then extended to larger companies with more ambitious aims around general remote patient monitoring and management using digital systems, which have been in development for some time but saw more launches and announcements as progress accelerated.

Electronic skin patches as a product category is extremely diverse, meaning different drivers, regulatory situations, and underlying trends in many of the different markets where skin patches are relevant. For example, as more funding became available around pandemic response options, 2020 and 2021 also saw a significant revision of the reimbursement amounts awarded to mobile cardiac telemetry devices in the US, drastically altering the margins and outlook for certain product types. Such changes are discussed at length in the report, both in the general discussion and in relation to responses and impact on specific players. Each product sector has a drastically different set of drivers, competitive landscape and outlook, and skin patch-based options fit within each in a very unique way.

This latest report from IDTechEx comes as part of a wider portfolio of reports in wearable technology. IDTechEx are a leading provider of market intelligence and technology scouting across wearable technology and many other related areas, and this report builds on a decade of experience and coverage of wearable products and related market areas. All report purchases come with additional access to the analyst team, including open discussion with the authors which can be used to clarify conclusions, review data, and ask questions about strategy. IDTechEx also work extensively as consultants and advisors to many companies from across the world and value chain, so have experience in developing technology and market strategies for players as required. For more information about the report, to request sample pages, or to ask any specific questions to the authors in the analyst team, please contact research@IDTechEx.com.

About IDTechEx

IDTechEx guides your strategic business decisions through its Research, Subscription and Consultancy products, helping you profit from emerging technologies. For more information, contact research@IDTechEx.com or visit www.IDTechEx.com.

Images download:

https://www.dropbox.com/sh/jowa7ljpk7kdvrt/AABV5tQPdIt_7JW_Te0ZEsL5a?dl=0

Media Contact:

Natalie Moreton
Digital Marketing Manager
press@IDTechEx.com
+44(0)1223 812300

Social Media Links:

Twitter: https://www.twitter.com/IDTechEx

LinkedIn: https://www.linkedin.com/company/idtechex/

Facebook: https://www.facebook.com/IDTechExResearch

IDTechEx Logo

Photo: https://mma.prnewswire.com/media/1552871/IDTechEx_Skin_Patches.jpg

Logo: https://mma.prnewswire.com/media/478371/IDTechEx_Logo.jpg

© 2021 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.